Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022660
Disease: Kidney Failure, Acute
Kidney Failure, Acute
0.010 Biomarker disease BEFREE Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3. 31691080 2020
CUI: C0034069
Disease: Pulmonary Fibrosis
Pulmonary Fibrosis
0.010 Biomarker disease BEFREE Here we investigate the expression of two ABC transporters, P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), in human IPF lung tissue and two different bleomycin-induced mouse models of pulmonary fibrosis. 31419911 2020
CUI: C0267008
Disease: Erythroplakia of mouth
Erythroplakia of mouth
0.010 AlteredExpression disease BEFREE Strikingly, we observed that the expression of podoplanin and ABCG2 within a single pre-neoplastic OE lesion significantly correlate with subsequently developing multiple and multifocal carcinomas, thus to some extent demonstrating the concept of field cancerization. 31300272 2020
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.010 AlteredExpression disease BEFREE In conclusion, BDL decreases the function and expression of brain BCRP in rats, leading to increased brain distribution of AZT, which in turn enhances AZT CNS toxicity, leading to mitochondrial dysfunction, neuronal damage, and ultimately cognitive dysfunction. 31142800 2020
CUI: C0553694
Disease: Oropharyngeal disorders
Oropharyngeal disorders
0.010 AlteredExpression group BEFREE However, murine lungs expressed increased levels of P-gp and BCRP after oropharyngeal and subcutaneous bleomycin administration. 31419911 2020
CUI: C1800706
Disease: Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
0.010 AlteredExpression disease BEFREE We report that P-gp and BCRP expression in IPF patient lungs was comparable to controls. 31419911 2020
CUI: C0007115
Disease: Malignant neoplasm of thyroid
Malignant neoplasm of thyroid
0.010 GeneticVariation disease BEFREE In this study, we aimed to evaluate how CYP3A4/5 and ABC transporter polymorphisms affected the mean steady-state dose-adjusted plasma trough concentrations (C<sub>0</sub>) of lenvatinib in a cohort of 40 Japanese patients with thyroid cancer. 30931962 2019
CUI: C0008350
Disease: Cholelithiasis
Cholelithiasis
0.010 GeneticVariation disease BEFREE A second ABC transporter, the hepatic phosphatidylcholine translocase ABCB4, increases the risk for gallstone disease, gallbladder cancer and chronic liver diseases in general, whereas the common PNPLA3 risk variant p.I148M decreases gallstone risk. 30608254 2019
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.010 AlteredExpression disease BEFREE Gene expression of P-gp and BCRP was reduced in oxazolone-treated skin and the skin of patients with atopic dermatitis or psoriasis. 31512001 2019
CUI: C0013595
Disease: Eczema
Eczema
0.010 AlteredExpression disease BEFREE Gene expression of P-gp and BCRP was reduced in oxazolone-treated skin and the skin of patients with atopic dermatitis or psoriasis. 31512001 2019
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.010 GeneticVariation disease BEFREE ABCG2 SNP rs2231142 and the gout comorbidities including nephrolithiasis and CKD were associated (<i>P</i> = 0.014 and <i>P</i> = 0.026). 31367212 2019
CUI: C0036572
Disease: Seizures
Seizures
0.010 AlteredExpression phenotype BEFREE Based on our previous studies, we hypothesized that glutamate released during seizures activates cytosolic phospholipase A2 (cPLA2), resulting in P-gp and BCRP overexpression. 31661303 2019
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.010 Biomarker group BEFREE Information about BCRP function in EVTs is limited, however placental exposure to bacterial/viral infection leads to BCRP downregulation in syncitiotrophoblasts. 31561453 2019
CUI: C0240066
Disease: Iron deficiency
Iron deficiency
0.010 Biomarker disease BEFREE Additionally, a larger amount of ABC transporter genes was induced or suppressed by iron deficiency under Cd exposure, indicating that this family may play important roles in Fe/Cd uptake and transport. 30665365 2019
CUI: C0392525
Disease: Nephrolithiasis
Nephrolithiasis
0.010 GeneticVariation disease BEFREE ABCG2 SNP rs2231142 and the gout comorbidities including nephrolithiasis and CKD were associated (<i>P</i> = 0.014 and <i>P</i> = 0.026). 31367212 2019
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.010 GeneticVariation disease BEFREE In this study, we aimed to evaluate how CYP3A4/5 and ABC transporter polymorphisms affected the mean steady-state dose-adjusted plasma trough concentrations (C<sub>0</sub>) of lenvatinib in a cohort of 40 Japanese patients with thyroid cancer. 30931962 2019
Malignant neoplasm of gastrointestinal tract
0.010 AlteredExpression disease BEFREE These results indicate that gastrointestinal cancer cell lines expressing high levels of ABCG2 are enriched with CSCs and show low rates of 5-ALA staining, but 5-ALA staining rates can be improved by inhibition of ABCG2. 31083682 2019
CUI: C0747820
Disease: Malaria, antepartum
Malaria, antepartum
0.010 AlteredExpression disease BEFREE Additionally, a decrease in placental Abca1 (ABCA1), Abcb1b (P-glycoprotein), Abcb9 and Abcg2 (BCRP) expression was observed in MiP mice. 31391498 2019
CUI: C0750952
Disease: Biliary Tract Cancer
Biliary Tract Cancer
0.010 AlteredExpression disease BEFREE We then demonstrated that knockdown of GPX4, CAT, or GSR induced chemoresistance through elevation of ROS level and activation of Nrf2-ABCG2 pathway in BTC cell lines. 31590928 2019
CUI: C0796074
Disease: MOHR-TRANEBJAERG SYNDROME
MOHR-TRANEBJAERG SYNDROME
0.010 AlteredExpression disease BEFREE The present study observed that in ovarian cancer cells, the expression of ABCG2 was significantly upregulated in response to cis-diamminedichloroplatinum (cisplatin/DDP) treatment, in addition the expression of NOS1 exhibited an increasing trend. 30675218 2019
CUI: C0947622
Disease: Cholecystolithiasis
Cholecystolithiasis
0.010 GeneticVariation disease BEFREE A second ABC transporter, the hepatic phosphatidylcholine translocase ABCB4, increases the risk for gallstone disease, gallbladder cancer and chronic liver diseases in general, whereas the common PNPLA3 risk variant p.I148M decreases gallstone risk. 30608254 2019
CUI: C1266025
Disease: Traditional Serrated Adenoma
Traditional Serrated Adenoma
0.010 AlteredExpression disease BEFREE In these two cell lines, the HDAC inhibitors suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA) significantly increased ABCB1 expression at the mRNA and protein levels, whereas they had no evident effect on ABCG2 protein expression. 31289473 2019
CUI: C1510472
Disease: Drug Dependence
Drug Dependence
0.010 AlteredExpression group BEFREE Thus, prolonged exposure to commonly abused drugs, ethanol and cocaine, alters the expression of Abcb1/ABCB1 and Abcg2/ABCG2 mRNA and protein levels in brain areas that play a role in drug dependence. 29978425 2019
CUI: C2316786
Disease: Chronic kidney disease stage 2
Chronic kidney disease stage 2
0.010 GeneticVariation disease BEFREE Group CKD stage = 1 were significantly different from those in group CKD stage≥2 regarding genotypes of ABCG2 gene polymorphism, while they were not significantly different from those in group CKD stage≥3. 31367212 2019
CUI: C2316787
Disease: Chronic kidney disease stage 3
Chronic kidney disease stage 3
0.010 GeneticVariation disease BEFREE Group CKD stage = 1 were significantly different from those in group CKD stage≥2 regarding genotypes of ABCG2 gene polymorphism, while they were not significantly different from those in group CKD stage≥3. 31367212 2019